Is Depo-Provera birth control to blame for this woman’s brain tumor? A lawsuit alleges Pfizer failed to warn of potential risk.
Read Original Source
WESTWEGO, La. — Robin Phillip’s fresh haircut is dyed her favorite color — green. But beneath the dye job is a scar that runs along the side of her head, the result of two craniotomies. Limited time: Save 25% on NBC News subscription Get exclusive reporting, live Q&As and ad-free reading. For years, Phillip, 45, suffered from what she thought were migraines.
AI Summary
Main Idea: Pfizer is facing a lawsuit from women, including Robin Phillip, who say Depo-Provera may have caused brain tumors and that the company failed to warn users about the risk.
Key Points:
- Robin Phillip says years of Depo-Provera use came before she was diagnosed with an intracranial meningioma, a brain tumor that led to multiple surgeries and lasting health problems.
- More than 1,000 women are suing Pfizer, arguing the company knew about possible tumor risks and should have warned patients sooner.
- Recent studies have found a possible link between Depo-Provera and meningioma, but doctors say the research is observational and does not prove the drug caused the tumors.
- Pfizer says the drug is safe and that the FDA did not approve the warning it sought to add to U.S. labels, while other countries have already updated their labels.
Impact on the People
Negative Impact
If Depo-Provera carries a small tumor risk, some patients may face more scans, surgeries, and worry, and Pfizer could face costly lawsuits and label changes.
Positive Impact
The new studies and lawsuit may push clearer drug warnings, helping patients and doctors make safer birth control choices.
How did each entity affect people?
Rate how each entity in this article affected the American people.
- Primary:Pfizercompany
- Primary:Robin Phillipperson
Candidate Entities8 candidates · 5 weighted vote min · 70% decision
- PfizercompanyPrimaryEvaluated
Central company defendant; the article focuses on allegations that it failed to warn about Depo-Provera risks.
Include 0 (0%)Ignore 0 (0%)5 to threshold - Robin PhillippersonPrimaryEvaluated
The lawsuit plaintiff and central personal case study whose brain tumor and Depo-Provera use drive the story.
Include 0 (0%)Ignore 0 (0%)5 to threshold - Dr. Colleen DennypersonContextCandidate
Named OB-GYN quoted on the overall risk and patient tradeoffs.
Include 0 (0%)Ignore 0 (0%)5 to threshold - Dr. David RaleighpersonContextCandidate
Named medical expert quoted about the possible hormone-menigioma link and clinical implications.
Include 0 (0%)Ignore 0 (0%)5 to threshold - Dr. Nisha VermapersonContextCandidate
Named ACOG adviser quoted on the organization’s caution about the study and risk discussion.
Include 0 (0%)Ignore 0 (0%)5 to threshold - Ellen RelkinpersonContextCandidate
Lawyer representing Phillip and other plaintiffs; provides the lawsuit’s central legal framing.
Include 0 (0%)Ignore 0 (0%)5 to threshold - JAMA Neurologyeducational / research institutionMinorCandidate
Named journal where a key study linking Depo-Provera and meningioma was published.
Include 0 (0%)Ignore 0 (0%)5 to threshold
Comments 0
Comments here are the same thread shown when this article appears in The Pulse.
No comments on this article yet.
Sign in to comment